Daily BriefsEvent-Driven

Daily Brief Event-Driven: A/H Premium Tracker (To 28 Mar 2024):  Liquid AH Premia Still Very Wide and more

In today’s briefing:

  • A/H Premium Tracker (To 28 Mar 2024):  Liquid AH Premia Still Very Wide
  • Updated Tool (31Mar24) & “Diff File Generator” For TSE “Mgmt Conscious of Capital Cost/Stock Price”
  • Merger Arb Mondays (01 Apr) – SciClone, IntelliCentrics, CIMC Vehicles, Lawson, Roland DG, MMA
  • SciClone Pharma (6600 HK): Privatisation At IPO Price
  • EQD / NSE Volatility Update / 25-Mar-24 to 29-Mar-24


A/H Premium Tracker (To 28 Mar 2024):  Liquid AH Premia Still Very Wide

By Travis Lundy

  • The New/Better A-H Premium Tracker has tables, charts, measures galore to track A/H premium positioning, southbound and northbound positioning/volatility in pairs over time, etc.
  • SOUTHBOUND’s consecutive buying streak ended on Monday, and a new buying streak started Tuesday. NORTHBOUND net bought the dip. Last week’s (double long) choice Longyuan Power was up 5.24%.
  • Narrow AH premia narrowed some. Wider AH premia saw Hs outperform. There is a LOT of spread left in this market.  7 recommendations this week.

Updated Tool (31Mar24) & “Diff File Generator” For TSE “Mgmt Conscious of Capital Cost/Stock Price”

By Travis Lundy

  • In mid-January, the TSE announced a “name-and-shame” list where they listed all the companies which had put forth a disclosure about 【資本コストや株価を意識した経営の実現に向けた対応】. But they did not actually shame.
  • The list shows which companies have disclosed a policy/consideration. But no data/links. We have the links, and we are weeks ahead of the TSE. Working to get months ahead.
  • We created a tool to name everyone, show their reports, provide links, and now a new tool. Put in a name, see the difference between the Old/New Reports.


SciClone Pharma (6600 HK): Privatisation At IPO Price

By David Blennerhassett


EQD / NSE Volatility Update / 25-Mar-24 to 29-Mar-24

By Sankalp Singh

  • On-The-Run Quarterly Options now capture India General Elections. Position buildup can be seen in the 21,000 put and 24,000 call strikes
  • Weekly and Monthly contract risk premia being squeezed lower due to holiday shortened trading but Quarterly contracts exhibit vol richness
  • Scale back short gamma exposure as reward-risk unappealing at current IV levels

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars